Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Clinical trial NCT00660257 · COMPLETED

Trial details

NCT number: NCT00660257
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pandemic Influenza Vaccine Prevention Pandemic Influenza

Start date: 2007-01-01
Primary completion: 2007-03-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.